Since the immune response to CMV often leads to the accumulation of T and adaptive-like NK cells expressing the activating receptor NKG2C [44], we analyzed the proportion of the NKG2C+ cells in the CD56− and CD56+ T cell fractions and in the NK cells in PD patients and the HD group. This evidence concerns the gene NCAM1 and Huntington disease.